Furthermore, HSP105 itself may induce CD8+ T cells to become reactive towards tumor cells that express HSP105, using HSP105-DNA and HSP105-pulsed DC vaccines in mice (6–8). This evidence concerns the gene HSPH1 and neoplasm.